Laboratory Corporation of America Holdings

252.37+2.23+0.89%Vol 354.97K1Y Perf -8.43%
Feb 2nd, 2023 11:44 DELAYED
BID252.14 ASK252.59
Open249.78 Previous Close250.14
Pre-Market249.80 After-Market-
 -0.34 -0.14%  - -
Target Price
267.50 
Analyst Rating
Moderate Buy 1.59
Potential %
5.39 
Finscreener Ranking
★★★+     51.03
Insiders Trans % 3/6/12 mo.
100/-82/-88 
Value Ranking
★★★★     54.91
Insiders Value % 3/6/12 mo.
100/-99/-99 
Growth Ranking
★★★★     59.35
Insiders Shares Cnt. % 3/6/12 mo.
100/-99/-99 
Income Ranking
★+     36.72
Price Range Ratio 52W %
57.90 
Earnings Rating
Sell
Market Cap22.36B 
Earnings Date
16th Feb 2023
Alpha0.00 Standard Deviation0.08
Beta1.02 

Today's Price Range

247.35254.51

52W Range

200.32290.20

5 Year PE Ratio Range

10.1026.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-1.60%
1 Month
6.23%
3 Months
11.38%
6 Months
-0.93%
1 Year
-8.43%
3 Years
42.61%
5 Years
47.44%
10 Years
176.49%

TickerPriceChg.Chg.%
LH252.372.22500.89
AAPL150.104.67003.21
GOOG107.726.29006.20
MSFT261.959.20003.64
XOM112.51-2.2300-1.94
WFC47.280.25000.53
JNJ163.96-0.9600-0.58
FB196.640.99000.51
GE82.630.31000.38
JPM139.48-0.1100-0.08
 
ProfitabilityValueIndustryS&P 500US Markets
31.40
15.70
20.10
15.20
10.75
RevenueValueIndustryS&P 500US Markets
11.20B
126.44
12.44
10.10
Earnings HistoryEstimateReportedSurprise %
Q03 20224.714.68-0.64
Q02 20224.674.966.21
Q01 20225.886.113.91
Q04 20215.906.7714.75
Q03 20214.776.8242.98
Q02 20215.646.138.69
Q01 20217.328.7920.08
Q04 20208.0510.5631.18
Earnings Per EndEstimateRevision %Trend
12/2022 QR4.06-10.38Negative
12/2022 FY19.83-2.32Negative
3/2023 QR4.14-4.83Negative
12/2023 FY17.67-2.27Negative
Next Report Date16th Feb 2023
Estimated EPS Next Report4.06
Estimates Count7
EPS Growth Next 5 Years %-
Volume Overview
Volume354.97K
Shares Outstanding88.60K
Shares Float72.01M
Trades Count8.31K
Dollar Volume89.10M
Avg. Volume569.84K
Avg. Weekly Volume500.83K
Avg. Monthly Volume545.25K
Avg. Quarterly Volume663.43K

Laboratory Corporation of America Holdings (NYSE: LH) stock closed at 250.14 per share at the end of the most recent trading day (a -0.79% change compared to the prior day closing price) with a volume of 732.78K shares and market capitalization of 22.36B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 72400 people. Laboratory Corporation of America Holdings CEO is Adam H. Schechter.

The one-year performance of Laboratory Corporation of America Holdings stock is -8.43%, while year-to-date (YTD) performance is 6.23%. LH stock has a five-year performance of 47.44%. Its 52-week range is between 200.32 and 290.2, which gives LH stock a 52-week price range ratio of 57.90%

Laboratory Corporation of America Holdings currently has a PE ratio of 13.00, a price-to-book (PB) ratio of 2.13, a price-to-sale (PS) ratio of 1.93, a price to cashflow ratio of 11.30, a PEG ratio of 2.32, a ROA of 9.36%, a ROC of 11.40% and a ROE of 18.48%. The company’s profit margin is 10.75%, its EBITDA margin is 20.10%, and its revenue ttm is $11.20 Billion , which makes it $126.44 revenue per share.

Of the last four earnings reports from Laboratory Corporation of America Holdings, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $4.06 for the next earnings report. Laboratory Corporation of America Holdings’s next earnings report date is 16th Feb 2023.

The consensus rating of Wall Street analysts for Laboratory Corporation of America Holdings is Moderate Buy (1.59), with a target price of $267.5, which is +5.39% compared to the current price. The earnings rating for Laboratory Corporation of America Holdings stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Laboratory Corporation of America Holdings has a dividend yield of 1.18% with a dividend per share of $2.88 and a payout ratio of -%.

Laboratory Corporation of America Holdings has a Neutral technical analysis rating based on Technical Indicators (ADX : 17.31, ATR14 : 4.50, CCI20 : -15.24, Chaikin Money Flow : 0.32, MACD : 3.94, Money Flow Index : 37.18, ROC : -0.62, RSI : 54.99, STOCH (14,3) : 35.16, STOCH RSI : 0.00, UO : 56.73, Williams %R : -64.84), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Laboratory Corporation of America Holdings in the last 12-months were: Adam H. Schechter (Option Excercise at a value of $0), Amy B. Summy (Option Excercise at a value of $0), Amy B. Summy (Sold 249 shares of value $65 290 ), Brian J. Caveney (Buy at a value of $40 852), Brian J. Caveney (Option Excercise at a value of $0), D. Gary Gilliland (Option Excercise at a value of $0), Garheng Kong (Option Excercise at a value of $0), Glenn A. Eisenberg (Option Excercise at a value of $4 722 543), Glenn A. Eisenberg (Sold 57 100 shares of value $13 417 023 ), Jean-Luc Belingard (Option Excercise at a value of $0), Jeffrey A. Davis (Option Excercise at a value of $0), Judith C. Seltz (Option Excercise at a value of $0), Kathryn E. Wengel (Option Excercise at a value of $0), Kerrii B. Anderson (Option Excercise at a value of $0), Lance V. Berberian (Option Excercise at a value of $0), Mark Schroeder (Option Excercise at a value of $0), Mark Schroeder (Sold 4 044 shares of value $1 069 592 ), Paul Kirchgraber (Option Excercise at a value of $0), Peter J. Wilkinson (Option Excercise at a value of $112 435), Peter J. Wilkinson (Sold 2 576 shares of value $665 635 ), Peter M. Neupert (Option Excercise at a value of $0), Richelle P. Parham (Option Excercise at a value of $0), Robert Sanders Williams (Option Excercise at a value of $0), Robert Sanders Williams (Sold 572 shares of value $156 145 ), Sandra D. van der Vaart (Option Excercise at a value of $0), Sandra D. van der Vaart (Sold 3 046 shares of value $842 576 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (63.64 %)
6 (60.00 %)
7 (70.00 %)
Moderate Buy
1 (9.09 %)
1 (10.00 %)
1 (10.00 %)
Hold
3 (27.27 %)
3 (30.00 %)
2 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.59
Moderate Buy
1.65
Strong Buy
1.45

Laboratory Corporation of America Holdings

Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.

CEO: Adam H. Schechter

Telephone: +1 336 229-1127

Address: 358 South Main Street, Burlington 27215, NC, US

Number of employees: 72 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

56%44%

Bearish Bullish

61%39%

Bearish Bullish

59%41%

TipRanks News for LH

Mon, 31 Oct 2022 04:25 GMT Laboratory (LH) Receives a Buy from Mizuho Securities

- TipRanks. All rights reserved.

Wed, 03 Aug 2022 02:29 GMT Laboratory (LH) Receives a Buy from Robert W. Baird

- TipRanks. All rights reserved.

Mon, 01 Aug 2022 12:36 GMT Analysts Offer Insights on Healthcare Companies: Laboratory (LH), Teleflex (TFX) and Amedisys (AMED)

- TipRanks. All rights reserved.

Mon, 01 Aug 2022 05:15 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (MOH), Laboratory (LH) and Amedisys (AMED)

- TipRanks. All rights reserved.

News

Stocktwits